Literature DB >> 32209476

OXR1A, a Coactivator of PRMT5 Regulating Histone Arginine Methylation.

Mingyi Yang1, Xiaolin Lin1, Filip Segers2, Rajikala Suganthan3, Gunn A Hildrestrand3, Johanne E Rinholm3, Per Arne Aas4, Mirta M L Sousa5, Sverre Holm2, Nils Bolstad6, David Warren6, Rolf K Berge7, Rune F Johansen3, Arne Yndestad2, Elise Kristiansen3, Arne Klungland3, Luisa Luna3, Lars Eide6, Bente Halvorsen2, Pål Aukrust8, Magnar Bjørås9.   

Abstract

Oxidation resistance gene 1 (OXR1) protects cells against oxidative stress. We find that male mice with brain-specific isoform A knockout (Oxr1A-/-) develop fatty liver. RNA sequencing of male Oxr1A-/- liver indicates decreased growth hormone (GH) signaling, which is known to affect liver metabolism. Indeed, Gh expression is reduced in male mice Oxr1A-/- pituitary gland and in rat Oxr1A-/- pituitary adenoma cell-line GH3. Oxr1A-/- male mice show reduced fasting-blood GH levels. Pull-down and proximity ligation assays reveal that OXR1A is associated with arginine methyl transferase PRMT5. OXR1A-depleted GH3 cells show reduced symmetrical dimethylation of histone H3 arginine 2 (H3R2me2s), a product of PRMT5 catalyzed methylation, and chromatin immunoprecipitation (ChIP) of H3R2me2s shows reduced Gh promoter enrichment. Finally, we demonstrate with purified proteins that OXR1A stimulates PRMT5/MEP50-catalyzed H3R2me2s. Our data suggest that OXR1A is a coactivator of PRMT5, regulating histone arginine methylation and thereby GH production within the pituitary gland.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arginine Methylation; Growth hormone; H3R2me2s; NAFLD; Non-alcoholic fatty liver disease; OXR1; Oxidation resistance gene 1; PRMT1; PRMT5; brain-liver axis; epigenetic regulation; neuroendocrine regulation; pituitary gland; protein arginine methyltransferase

Mesh:

Substances:

Year:  2020        PMID: 32209476     DOI: 10.1016/j.celrep.2020.02.063

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  Cellular pathways influenced by protein arginine methylation: Implications for cancer.

Authors:  Jian Xu; Stéphane Richard
Journal:  Mol Cell       Date:  2021-10-06       Impact factor: 17.970

2.  The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression.

Authors:  Jianchao Zhang; Xiaokai Fan; Yunfan Zhou; Liang Chen; Hai Rao
Journal:  J Exp Clin Cancer Res       Date:  2022-06-02

3.  Arginine methylation: the promise of a 'silver bullet' for brain tumours?

Authors:  Sabrina F Samuel; Antonia Barry; John Greenman; Pedro Beltran-Alvarez
Journal:  Amino Acids       Date:  2021-01-06       Impact factor: 3.520

Review 4.  Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors.

Authors:  Ernesto Guccione; Megan Schwarz; Federico Di Tullio; Slim Mzoughi
Journal:  Curr Opin Pharmacol       Date:  2021-05-27       Impact factor: 4.768

Review 5.  PRMT5: a putative oncogene and therapeutic target in prostate cancer.

Authors:  Elena Beketova; Jake L Owens; Andrew M Asberry; Chang-Deng Hu
Journal:  Cancer Gene Ther       Date:  2021-04-14       Impact factor: 5.854

6.  The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour.

Authors:  Enrico Castroflorio; Joery den Hoed; Daria Svistunova; Mattéa J Finelli; Alberto Cebrian-Serrano; Silvia Corrochano; Andrew R Bassett; Benjamin Davies; Peter L Oliver
Journal:  Cell Mol Life Sci       Date:  2020-12-19       Impact factor: 9.261

Review 7.  Preventing Neurodegeneration by Controlling Oxidative Stress: The Role of OXR1.

Authors:  Michael R Volkert; David J Crowley
Journal:  Front Neurosci       Date:  2020-12-15       Impact factor: 4.677

8.  Gene therapy targeting inflammatory pericytes corrects angiopathy during diabetic wound healing.

Authors:  Wenxv Jin; Xiong Chen; Lingguo Kong; Chongqing Huang
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

9.  MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis.

Authors:  Shengyu Li; Lishuo Wu; Meigang Ma; Longxiu Yang; Chao Qin
Journal:  Ann Transl Med       Date:  2022-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.